epitope corresponding to amino acids 31-100 mapping near the N-terminus of INSIG-1 of human origin
Modification Notes
INSIG-1 and INSIG-2 play distinct roles in a negative-feedback mechanism for cholesterol synthesis. INSIG-1 is highly expressed in liver and fibroblast cell lines. INSIG-1 localizes to the endoplasmic reticulum (ER) and binds the sterol-sensing domain of SREBP cleavage-activating protein (SCAP). Sterol induces INSIG-1 binding to SCAP. INSIG-2, another ER protein, binds SCAP in a sterol-regulated manner. Thus, INSIG-1 and INSIG-2 block the export of SCAP from the ER and ultimately inhibit cholesterol synthesis by preventing the proteolytic processing of SREBPs by Golgi enzymes. INSIG-1 is encoded by the Insulin-induced gene (INSIG-1). INSIG-1 gene expression is suppressed by oxysterols and restored following the introduction of the hypocholester-olemic agent LY295427. The negative feedback mechanism is absent in mutant CHO cells with a point mutation in one SCAP allele within the sterol-sensing domain. The mutant cells constitutively cleave SREBP in the presence of sterols. The critical role of INSIG-1 and INSIG-2 in cholesterol metabolism may be exploited as a therapeutic effect for hypercholesterolemia.
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of INSIG-1 of human origin by WB, IP, IF and ELISA:
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 31-100 mapping near the N-terminus of INSIG-1 of human origin
Tissue Specificity
epitope corresponding to amino acids 31-100 mapping near the N-terminus of INSIG-1 of human origin